Request an Appointment:
Online or Call 1-888-824-0200

Cancer Surgery

Cancer surgery

For many people with cancer, surgery is a vital part of their treatment--one that can speed their recovery and improve their chances for a healthy future. However, cancer surgeries can be extremely complex, so it’s important that patients find a surgeon and hospital they trust.

U.S. News & World Report regularly ranks the University of Chicago Medicine's cancer program among the top in the nation. Our surgeons are recognized for their comprehensive knowledge and for using sophisticated techniques and technology to provide the best possible outcomes. In addition, our surgeons recognize how cancer surgery can impact a patient and his or her family. Our surgeons take the time to discuss with each patient the range of options available, striving to provide the right treatment to the right patient at the right time.

One area where we have made an important impact on cancer diagnosis and treatment is through minimally invasive surgery. Minimally invasive surgery is the practice of performing surgical procedures through tiny cuts rather than long incisions. In some cases, our surgeons can even remove a tumor through a body opening (such as the nose or anus), and do not need to make any incisions at all. Whenever possible, our surgeons use minimally invasive techniques to speed recovery and to reduce pain, scarring, and tissue damage.

Surgeons at the University of Chicago medical center were among the first in the region to use the da Vinci Surgical System, a state-of-the-art robotic device, to assist with some minimally invasive procedures. This high-tech, computer-enhanced system can help surgeons operate even more precisely, and make surgery less disruptive for the patient. Today, our surgeons use this system to treat many types of cancer.

Request an Appointment

» Request an appointment
» Request a second opinion

For brain, gynecologic, lung, and pediatric cancer appointments:

For all other cancer appointments:


CAR T-cell Therapy: Scott McIntyre’s Story

After many treatments for his B-cell lymphoma failed, Scott McIntyre became the first UChicago Medicine patient to undergo CAR T-cell gene therapy in a clinical trial. UChicago Medicine was the first hospital in Illinois certified to offer CAR T-cell therapy.

Clinical Trials